ALPINE IMMUNE SCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Alpine Immune Sciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q1 2024.
Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $3.99M, a 56.3% increase year-over-year.
Alpine Immune Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $12.1M, a 21.8% increase year-over-year.
Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 10.2% increase from 2022.
Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.65M, a 54.6% increase from 2021.
Alpine Immune Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.24M, a 50.7% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$12.1M	$3.99M	+$1.44M	+56.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$10.6M	$2.8M	+$334K	+13.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-20
Q3 2023	$10.3M	$2.65M	+$99K	+3.88%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$10.2M	$2.62M	+$286K	+12.2%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$9.91M	$2.55M	+$263K	+11.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$9.65M	$2.47M	+$1.01M	+69.1%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-20
Q3 2022	$8.64M	$2.56M	+$917K	+56%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$7.72M	$2.34M	+$790K	+51.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$6.93M	$2.29M	+$692K	+43.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$6.24M	$1.46M	+$511K	+53.8%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-20
Q3 2021	$5.73M	$1.64M	+$665K	+68.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$5.06M	$1.55M	+$313K	+25.4%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$4.75M	$1.6M	+$611K	+62%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$4.14M	$949K	+$169K	+21.7%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-23
Q3 2020	$3.97M	$973K	+$148K	+17.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$3.82M	$1.23M	+$550K	+80.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-10
Q1 2020	$3.27M	$986K	+$232K	+30.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	$3.04M	$780K	+$49K	+6.7%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-17
Q3 2019	$2.99M	$825K	+$281K	+51.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	$2.71M	$682K	+$159K	+30.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-11
Q1 2019	$2.55M	$754K	+$243K	+47.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	$2.31M	$731K	+$422K	+137%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-18
Q3 2018	$1.89M	$544K	+$315K	+138%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	$1.57M	$523K	+$275K	+111%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018	$1.3M	$511K	+$459K	+883%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$838K	$309K	+$1.65M		Oct 1, 2017	Dec 31, 2017	10-K	2020-03-30
Q3 2017	-$813K	$229K	+$217K	+1808%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	-$1.03M	$248K	-$452K	-64.6%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$578K	$52K	-$655K	-92.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-14
Q4 2016	$77K	-$1.34M			Oct 1, 2016	Dec 31, 2016	10-K	2019-03-18
Q3 2016		$12K			Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016		$700K			Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-21
Q1 2016		$707K			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-02

* An asterisk sign (*) next to the value indicates that the value is likely invalid.